Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATShares Issued
Ratios

Arcus Biosciences (RCUS) Leases (2020 - 2022)

Historic Leases for Arcus Biosciences (RCUS) over the last 3 years, with Q3 2022 value amounting to $102.1 million.

  • Arcus Biosciences' Leases rose 18672.19% to $102.1 million in Q3 2022 from the same period last year, while for Sep 2022 it was $102.1 million, marking a year-over-year increase of 18672.19%. This contributed to the annual value of $105.0 million for FY2021, which is 72128.16% up from last year.
  • As of Q3 2022, Arcus Biosciences' Leases stood at $102.1 million, which was up 18672.19% from $104.0 million recorded in Q2 2022.
  • Arcus Biosciences' Leases' 5-year high stood at $105.0 million during Q4 2021, with a 5-year trough of $12.2 million in Q1 2021.
  • For the 3-year period, Arcus Biosciences' Leases averaged around $63.9 million, with its median value being $69.1 million (2021).
  • Over the last 5 years, Arcus Biosciences' Leases had its largest YoY gain of 74123.17% in 2022, and its largest YoY loss of 18672.19% in 2022.
  • Arcus Biosciences' Leases (Quarter) stood at $12.8 million in 2020, then surged by 721.28% to $105.0 million in 2021, then dropped by 2.76% to $102.1 million in 2022.
  • Its Leases stands at $102.1 million for Q3 2022, versus $104.0 million for Q2 2022 and $103.0 million for Q1 2022.